Elutia (ELUT) Price & Analysis

Compare

74 Followers

ELUT Stock Chart & Stats

$0.69

$0.15(4.48%)

At close: Jan 08 4:00 PM EST

$0.69

$0.15(4.48%)

Day’s Range― - ―

52-Week Range$0.58 - $4.84

Previous CloseN/A

Volume4.31K

Average Volume (3M)364.18K

Market Cap

$39.00M

Enterprise Value$120.52M

Total Cash (Recent Filing)$4.72M

Total Debt (Recent Filing)$26.32M

Price to Earnings (P/E)―

Beta-0.06

Next Earnings

Mar 04, 2026

EPS Estimate

-0.12

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.19

Shares Outstanding38,081,936

10 Day Avg. Volume362,745

30 Day Avg. Volume364,181

Financial Highlights & Ratios

PEG Ratio0.20

Price to Book (P/B)-2.35

Price to Sales (P/S)4.46

P/FCF Ratio-4.66

Enterprise Value/Market Cap3.09

Enterprise Value/Revenue5.72

Enterprise Value/Gross Profit12.44

Enterprise Value/Ebitda-7.97

Forecast

1Y Price Target

$3.50

Price Target Upside407.25% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering2

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Market AcceptanceProduct uptake for EluPro is robust, with substantial same-center sales growth and over 100 active accounts, indicating strong market acceptance.

Product PositioningEluPro is positioned as a superior product with antibiotic properties and a soft biomatrix for better patient comfort and pacemaker protection, likely to capture significant market share.

Bears Say

Product PerformanceSimpliDerm was below expectations in Q4 due to partner Tiger working through its reorganization process.

Elutia News

Elutia management to meet with Lake Street

Meeting to be held in New York on December 4 hosted by Lake Street. Published first on TheFly...

11d ago

ELUT

Elutia reports Q3 EPS (19c) vs. (33c) last year

Reports Q3 revenue $3.3M vs. $3.6M last year. “Behind every breast reconstruction is a woman overcoming cancer,” said...

30d ago

ELUT

Aziyo Biologics Faces Nasdaq Delisting Risk Notice

An update from Aziyo Biologics ( ($ELUT) ) is now available. On November 7, 2025, Elutia Inc., a...

24d ago

ELUT

Elutia’s Earnings Call: Strategic Moves Amid Challenges

Aziyo Biologics, Inc. Class A (($ELUT)) has held its Q3 earnings call. Read on for the main highlights...

29d ago

ELUT

Elutia Inc. Advances NXT-41x Amid Financial Developments

Aziyo Biologics, Inc. Class A ( ($ELUT) ) has released its Q3 earnings. Here is a breakdown of...

29d ago

ELUT

Is ELUT a Buy, Before Earnings?

Aziyo Biologics, Inc. Class A (ELUT) is scheduled to report 3rd quarter earnings on 11/07/2025, before the market...

1M ago

ELUT

Aziyo Biologics Welcomes Guido J. Neels to Board

Aziyo Biologics ( ($ELUT) ) has shared an announcement. On October 10, 2025, Elutia Inc. announced the election...

2M ago

ELUT

Elutia appoints Guido Neels to board of directors

Elutia (ELUT) announced the appointment of Guido Neels to the Company’s Board of Directors. Mr. Neels will also...

2M ago

ELUT

Elutia Completes Sale of BioEnvelope to Boston Scientific

Aziyo Biologics ( ($ELUT) ) has shared an announcement. On October 1, 2025, Elutia Inc. announced the completion...

2M ago

ELUT

Top 3 Trending Stocks, According to Analysts – 10/1/2025

Wondering which stocks are trending today? TipRanks has calculated which stocks have received the greatest number of new...

2M ago

BSX

CCL

Elutia closes sale of its BioEnvelope business to Boston Scientific for $88M

Elutia (ELUT) announced the closing of the sale of its BioEnvelope business, including the EluPro and CanGaroo bioenvelopes,...

2M ago

BSX

ELUT

Elutia announces publication clinical, preclinical data on biologic envelope

Elutia (ELUT) announced the publication of clinical and preclinical data supporting the clinical utility of a biologic envelope...

3M ago

ELUT

Elutia price target lowered to $6 from $8 at Lake Street

Lake Street lowered the firm’s price target on Elutia (ELUT) to $6 from $8 and keeps a Buy...

3M ago

BSX

ELUT

Elutia Sells Device Business to Boston Scientific

Aziyo Biologics ( ($ELUT) ) has provided an announcement. On September 8, 2025, Elutia Inc. entered into an...

3M ago

ELUT

ELUT FAQ

What was Elutia’s price range in the past 12 months?

Elutia lowest stock price was $0.58 and its highest was $4.84 in the past 12 months.

What is Elutia’s market cap?

Elutia’s market cap is $39.00M.

When is Elutia’s upcoming earnings report date?

Elutia’s upcoming earnings report date is Mar 04, 2026 which is in 88 days.

How were Elutia’s earnings last quarter?

Elutia released its earnings results on Nov 06, 2025. The company reported -$0.19 earnings per share for the quarter, missing the consensus estimate of -$0.155 by -$0.035.

Is Elutia overvalued?

According to Wall Street analysts Elutia’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Elutia pay dividends?

Elutia does not currently pay dividends.

What is Elutia’s EPS estimate?

Elutia’s EPS estimate is -0.12.

How many shares outstanding does Elutia have?

Elutia has 38,081,936 shares outstanding.

What happened to Elutia’s price movement after its last earnings report?

Elutia reported an EPS of -$0.19 in its last earnings report, missing expectations of -$0.155. Following the earnings report the stock price went down -4.255%.

Which hedge fund is a major shareholder of Elutia?

Currently, no hedge funds are holding shares in ELUT

Company Description

Elutia

Aziyo Biologics (ELUT) is a biotechnology company focused on developing regenerative medicine solutions, primarily through the utilization of human-derived extracellular matrix (ECM) technology. The company operates in the medical device and tissue regeneration sectors, offering innovative products for surgical and wound care applications. Aziyo's core products include grafts and implants that promote healing and tissue regeneration, addressing critical medical needs in areas such as orthopedics, cardiovascular, and general surgery.

Elutia (ELUT) Earnings & Revenues

Historic Earnings Reports

ELUT Company Deck

ELUT Earnings Call

Q3 2025

0:00 / 0:00

Earnings Call Sentiment|Positive

Elutia's earnings call highlighted significant progress and strategic realignments, including the sale of its bioenvelope business, growth in key product lines, and improved financial metrics. However, challenges remain with a decline in overall sales, historical revenue declines in SimpliDerm, and ongoing litigation liabilities.View all ELUT earnings summaries

ELUT Stock 12 Month Forecast

Average Price Target

$3.50

▲(407.25% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","-1":"-$1","0.75":"$0.75","2.5":"$2.5","4.25":"$4.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$5.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$3.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$2.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,0.75,2.5,4.25,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.66,0.9938461538461538,1.3276923076923077,1.6615384615384614,1.9953846153846153,2.329230769230769,2.663076923076923,2.996923076923077,3.330769230769231,3.664615384615385,3.9984615384615387,4.332307692307692,4.666153846153846,{"y":5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.66,0.8784615384615385,1.096923076923077,1.3153846153846154,1.5338461538461539,1.7523076923076921,1.9707692307692306,2.189230769230769,2.4076923076923076,2.626153846153846,2.8446153846153845,3.063076923076923,3.2815384615384615,{"y":3.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.66,0.7630769230769231,0.8661538461538462,0.9692307692307692,1.0723076923076924,1.1753846153846155,1.2784615384615385,1.3815384615384616,1.4846153846153847,1.5876923076923077,1.6907692307692308,1.7938461538461539,1.896923076923077,{"y":2,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.34,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.74,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.22,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.28,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.5,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.21,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.76,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.13,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.04,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.16,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.88,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.91,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.66,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >